Cargando…
Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families
The 15q11.2 BP1-BP2 deletion (Burnside-Butler) syndrome is emerging as the most common cytogenetic finding in patients with neurodevelopmental or autism spectrum disorders (ASD) presenting for microarray genetic testing. Clinical findings in Burnside-Butler syndrome include developmental and motor d...
Autores principales: | Baldwin, Isaac, Shafer, Robin L., Hossain, Waheeda A., Gunewardena, Sumedha, Veatch, Olivia J., Mosconi, Matthew W., Butler, Merlin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914695/ https://www.ncbi.nlm.nih.gov/pubmed/33562221 http://dx.doi.org/10.3390/ijms22041660 |
Ejemplares similares
-
Parent-of-Origin Effects in 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome
por: Davis, Kyle W., et al.
Publicado: (2019) -
Magnesium Supplement and the 15q11.2 BP1–BP2 Microdeletion (Burnside–Butler) Syndrome: A Potential Treatment?
por: Butler, Merlin G.
Publicado: (2019) -
The 15q11.2 BP1-BP2 Microdeletion (Burnside–Butler) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Disorders
por: Rafi, Syed K., et al.
Publicado: (2020) -
Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature
por: Farrell, Martilias, et al.
Publicado: (2020) -
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
por: Cox, Devin M., et al.
Publicado: (2015)